Skip to main content

APPLIED DNA SCIENCES INC (APDN) Stock Forecast


Stock Price Forecast

Aug. 15, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading APPLIED DNA SCIENCES INC chart...

About the Company

Applied Biosystems is one of various brands under the Life Technologies brand of Thermo Fisher Scientific corporation. The brand is focused on integrated systems for genetic analysis, which include computerized machines and the consumables used within them (such as reagents). In 2008, a merger between Applied Biosystems and Invitrogen was finalized, creating Life Technologies. The latter was acquired by Thermo Fisher Scientific in 2014. Prior to 2008, the Applied Biosystems brand was owned by various entities in a corporate group parented by PerkinElmer. The roots of Applied Biosystems trace back to GeneCo (Genetic Systems Company), a pioneer biotechnology company founded in 1981 in Foster City, California. Through the 1980s and early 1990s, Applied Biosystems, Inc. operated independently and manufactured biochemicals and automated genetic engineering and diagnostic research instruments, including the principal brand of DNA sequencing machine used by the Human Genome Project consortium centers. Applied Biosystems' close ties to the consortium project led to the idea for the founding of Celera Genomics in 1998 as one of several independent competitors to the consortium. In 1993 Applied Biosystems, Inc., was delisted from the NASDAQ when it was acquired by the old company known then as Perkin-Elmer. As the PE Applied Biosystems Division under that parent in 1998, it became consolidated with other acquisitions as the primary PE Biosystems Division. In 1999 its parent company reorganized and changed its name to PE Corporation, and the PE Biosystems Group (formerly again became publicly traded, as a tracking stock of its parent, along with its sister tracking stock company, Celera Genomics. In 2000 the parent became Applera Corporation. The Applied Biosystems name also returned that year, in the name change of the tracking stock from PE Biosystems Group to Applera Corporation-Applied Biosystems Group, an S&P 500 company, which remains as a publicly traded operating group within Applera Corp., along with its sibling operating group, Applera Corporation-Celera Group. Applera derives its name from the combination of its two component groups' names, Appl(iedCel)era In November 2008, a merger between Applied Biosystems and Invitrogen was finalized "creating a global leader in biotechnology reagents and systems". The new company was called Life Technologies.

Exchange

Nasdaq

$2M

Total Revenue

72

Employees

$3M

Market Capitalization

-0.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on APPLIED DNA SCIENCES INC

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

18h ago, source: The Tennessean

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company ...

Applied DNA Regains Compliance with All Nasdaq Continued Listing ...

1mon ago, source: Ames Tribune

Applied DNA Sciences is a biotechnology company with over 20 years of experience in developing and commercializing polymerase chain reaction (PCR)-based applications for DNA production. Through its ...

Applied DNA Sciences: Fiscal Q3 Earnings Snapshot

5d ago, source: Seattle Post-Intelligencer

(APDN) on Thursday reported a fiscal third-quarter loss of $3.9 million, after reporting a profit in the same period ...

Applied DNA Regains Compliance with All Nasdaq Continued Listing ...

1mon ago, source: USA Today

STONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it ...

Applied DNA Regains Compliance with All Nasdaq Continued Listing ...

1mon ago, source: MyCentralJersey

Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com Web: https://investors.adnas.com SOURCE: Applied DNA Sciences, Inc. View the original press release on ACCESS Newswire ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
APPLIED DNA SCIENCES INC APDN Predict 3.39 -0.04 0.47
NEOGENOMICS INC NEO Predict 799.11 -64.89 0.94
UL Solutions Inc. ULS Predict 13814.73 42.25 12.64

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...